Health
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble – The Japan Times
Moderna said it was now expecting sales of between $15 billion and $18 billion from $20 billion estimated previously.
Moderna Inc. on Thursday cut its 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, as it struggles to ramp up production of its two-dose inoculation, sending its shares down nearly 11% in premarket trading.
The company’s sales target…
Continue Reading
-
General23 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General20 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business19 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News23 hours agoStory Bridge documents released amid cover-up claims